We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




First-In-Kind Flowable Collagen Liquid Fills Tissue Defects and Voids

By HospiMedica International staff writers
Posted on 06 Nov 2024
Print article
Image: The first-in-kind flowable collagen liquid can be used to fill tissue defects and voids (Photo courtesy of William Cabral)
Image: The first-in-kind flowable collagen liquid can be used to fill tissue defects and voids (Photo courtesy of William Cabral)

Challenging soft tissue defects and voids caused by injuries, diseases, congenital defects, or tumor removals represent a significant burden for both patients and the healthcare system. Now, a novel option for rapid and effective soft tissue restoration offers patients the potential of a more cost-effective treatment with more predictable outcomes and shorter healing times.

GeniPhys (Indianapolis, IN, USA) has received a patent from the U.S. Patent and Trademark Office, expanding the protection of its platform technology, Collymer, along with processing methods supporting material diversity applications. Collymer can be tailored and created into materials with various flexible shapes, structures, and mechanical properties to meet the unmet clinical needs in advanced wound care, soft tissue reconstruction in breast-conserving surgery/lumpectomy, aesthetics, orthopedics, and therapeutic cell and drug delivery.

GeniPhys aims for FDA 510(k) submission and clearance by the second quarter of 2025, which would allow entry into the advanced wound care market with its first product, the Collymer Self-Assembling Scaffold (SAS). This innovative product is applied as a flowable collagen liquid to fill tissue defects and voids. During application, the Collymer SAS conforms to the wound’s geometry before swiftly transforming into a fibrillar collagen scaffold. Its structural and biochemical signals mimic those of natural collagen, promoting full integration and remodeling of the tissue without causing inflammation or scar formation. This process enhances the likelihood of better patient outcomes, shorter healing times, and the potential for more affordable treatments.

Although Collymer SAS has broad applications across various surgical fields, GeniPhys is initially focusing on the advanced wound care market, which affects over 10 million patients with chronic, non-healing wounds. Simultaneously, GeniPhys will explore additional indications, such as in breast-conserving surgery (lumpectomy), where preclinical studies have indicated that Collymer SAS performs exceptionally as a first-of-its-kind regenerative breast tissue filler, with the potential to enhance both oncological and cosmetic results.

“Hard-to-heal soft tissue defects and voids due to injury, disease, congenital birth defects or tumor removal are a major burden to both patients and the health care system,” said Andy Eibling, GeniPhys CEO. “GeniPhys is answering a longtime need for novel options for rapid and effective soft tissue restoration.”

Related Links:
GeniPhys

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Phototherapy Eye Protector
EyeMax2
New
Vertebral Body Replacement System
Hydrolift

Print article

Channels

Surgical Techniques

view channel
Image: Synthetic images generated by each diffusion model contrasted with the corresponding real textural images of four types of polyps (Photo courtesy of UT at Austin)

AI-Assisted Imaging to Assist Endoscopists in Colonoscopy Procedures

Colorectal cancer is a major health concern in the United States, with the likelihood of developing the disease being 1 in 25 for women and 1 in 23 for men. Polyps, which are precursors to cancer, can... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.